Calcium supplementation for people with overweight or obesity 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Surgery vs preoperative pharmacological therapy and surgery

All‐cause mortality · adults with growth‐hormone secreting pituitary adenomas

The review found no eligible studies for this question.

1 finding from 1 review

Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary… 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Surgery vs Pharmacological therapy

All‐cause mortality · adults with growth‐hormone secreting pituitary adenomas

The review found no eligible studies for this question.

1 finding from 1 review

Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary… 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low glycaemic index (GI) or glycaemic load (GL) diets vs any other diet

All‐cause mortality · Adults or children with overweight or obesity

The review found no eligible studies for this question.

1 finding from 1 review

Low glycaemic index or low glycaemic load diets for people with overweight or obesity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Low glycaemic index (GI) or glycaemic load (GL) diets vs higher GI or GL diets

All‐cause mortality · Adults or children with overweight or obesity

The review found no eligible studies for this question.

1 finding from 1 review

Low glycaemic index or low glycaemic load diets for people with overweight or obesity 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Parathyroidectomy vs observation

All‐cause mortality · people with primary hyperparathyroidism

1 finding from 1 review

Parathyroidectomy for adults with primary hyperparathyroidism 2023 · Cochrane Headline outcomes only
2.11 [0.2, 22.6]
2 studies · 133 participants
Very low

Meglitinides vs sulphonylureas

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SGLT‐2 inhibitors vs sulphonylureas

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

GLP‐1 analogues inhibitors vs sulphonylureas

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Insulin analogues vs biphasic insulin

All‐cause mortality

It is very uncertain whether insulin analogues changes all‐cause mortality compared with biphasic insulin (very low certainty).

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
RR 3.02 [0.12, 73.53]
1 study · 263 participants
Very low

Telemedicine vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs sulphonylureas

All‐cause mortality

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 2426 participants
Moderate

Patient education vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Drug dosage reduction vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

All‐cause mortality · children and adolescents with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for the treatment of obesity in children and adolescents 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Recombinant human thyrotropin‐aided radioiodine vs radioiodine

All‐cause mortality

1 finding from 1 review

Recombinant human thyrotropin (rhTSH)‐aided radioiodine treatment for non‐toxic multinodular goitre 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Very low

Summary of findings: insulin detemir vs insulin glargine

All‐cause mortality

1 finding from 1 review

(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 763 participants
Low